HomeADIL • NASDAQ
add
Adial Pharmaceuticals Inc
Previous close
$2.32
Day range
$2.12 - $2.30
Year range
$0.77 - $14.00
Market cap
8.80M USD
Avg Volume
5.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.78M | -31.32% |
Net income | -1.92M | 33.01% |
Net profit margin | — | — |
Earnings per share | -0.37 | 86.55% |
EBITDA | -1.78M | 31.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.83M | -29.35% |
Total assets | 4.74M | -17.38% |
Total liabilities | 653.08K | -73.41% |
Total equity | 4.08M | — |
Shares outstanding | 4.05M | — |
Price to book | 0.95 | — |
Return on assets | -117.30% | — |
Return on capital | -138.87% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.92M | 33.01% |
Cash from operations | -1.22M | 30.17% |
Cash from investing | 350.00K | — |
Cash from financing | 3.38M | — |
Net change in cash | 2.51M | 243.43% |
Free cash flow | -186.19K | -45.68% |
About
Founded
2010
Headquarters
Website
Employees
6